ClinTex: Revolution of Medicine

August 27, 2020

Medicine discovery and development are continuously being made to produce products that are beneficial in the world of health. The stages involved in drug discovery and development are long enough to be distributed at the consumer level.

Increased use of drugs that are not accompanied by an increase in the ability to choose quality drugs will certainly harm the community. At the very least, a drug must pass phase III clinical trials to be marketable. The FDA reports that only about 25-30% of the drugs studied pass through phase III clinical trials. Phase IV clinical trials are conducted to monitor the safety and efficacy of drugs after the drug is launched on the market. To pass a phase I-III clinical trial, an ordinary drug takes a minimum of 5 years.

In clinical trials a large number of test volunteers are also needed. This causes the costs required for clinical trials of a drug to be very large. In addition, the greater the number of countries involved in clinical trials and the longer trial times, the greater the clinical trial costs incurred. Furthermore, drugs that will be marketed in developing countries also require greater costs and a longer clinical trial time.

Platform Clintex (Clinical Trials Intelligence).
Clinical Trials Intelligence is a distributed technology platform that incorporates predictive data analytics, machine learning (AI), and the innovative use of smart contracts to drive significant quality and operational improvements in clinical trials.

Clintex tries to find a way to solve the problems facing the pharmaceutical world. This platform moves quickly through open and transparent blockchain technology, making it easier to control.
We know that the discovery of new medicine is a very long and costly process and it is difficult to find volunteers to conduct clinical trials. Now Clintex provides an advanced workflow that creates a collaborative ecosystem in the pharmaceutical industry worldwide. This will have implications for a very large reduction in research costs because it has a data-sharing community function that has been found previously.

In the ecosystem all stakeholders gather and analyze each test carried out so that it is faster to find potential effects on the negative impacts that occur.

This is a new, more complex and affordable way to meet operational needs for a faster, safer and smarter distribution and quality.

Clintex has several solutions to solve problems faced by the pharmaceutical industry by using machine learning, predictive analytics, smart contracts and of course the use of Blockchain technology which is becoming hype in all fields, especially in this industry.

Clintex mission is to bring down the cost of medicine and improve the speed to market of new medicines for the people who need them, through vastly reducing development costs for the global pharmaceutical industry.

This platform is a decentralized software which is supported by people who have the best knowledge and expertise in the fields of pharmaceuticals, data analysis, clinical, software developers and blockchain experts.

Given that it is very difficult to find new types of drugs that can be used quickly, especially in the midst of the Covid-19 pandemic. Today, every pharmaceutical company will be able to save costs, speed up clinical trials and distribution and meet better drug quality and more efficient operations.

Roadmap

Q2 2018

CTi Data Model Design;

CTi-OEM Prototype Development.

Q3 2018

Pre Sale TGE;

Public TGE.

Q4 2018

CTi GUI Development (with Integrated CLX Wallet);

Blockchain Verification of CTi Pre-Processing Data.

Q1 2019

Blockchain Verification of CTi Pre-Processing Data;

CTi-OEM DEvelopment.

Q2 2019

CTi-PDA Development.

Q3 2019

CTi-PRR Development;

Migration on-chain of CTiClinical Data Statistical Summaries.

Q4 2019

CTi-RBM Development;

CTi-CDV Development.

Q1 2020

Cti-VMM Development.

Q2 2020

CTi-SIM Development.

Q3-Q4 2020

Migration on-chain of the CTi Data Model and CTi Processing Engine,

Our Team